When cells commit to meiosis, they undergo a single round of replication and then homologous chromosome pairing, meiotic recombination, and reductional segregation of the homologs during the first meiotic division. In yeast cells, the second chromosomal division is followed by the packaging of the four haploid products of meiosis into spores (for a review, see reference 7). A number of genes have been discovered (SPOF1, MER1, HOPI, SGA1, SP016, MEI4, RED1, and SP013) that are known to function exclusively during meiosis and whose expression is restricted to a characteristic time in the meiotic pathway (1, 6, 12, 17, 20, 22, 35, 37) . It is appealing to imagine that these genes are regulated in a coordinated fashion to ensure that they are expressed at the proper time and level during meiosis.
The signals that control entry into meiosis by the yeast Saccharomyces cerevisiae have been well studied and include a specific set of genetic as well as nutritional conditions (for a review, see reference 21) . Genetically, a cell must contain both mating-type loci (A Ta and AMTa) to express both the a2 and al proteins. These proteins function together to repress transcription of the RME1 gene, which encodes a repressor of meiosis (23) . The absence of RME1 protein allows expression of the IME1 protein, an inducer of meiosis (14) . The IME1 protein, in turn, functions to induce expression of IME2, a second inducer of meiosis (29, 30) . The nutritional signal required for the induction of meiosis, nitrogen starvation, feeds into the regulatory cascade by serving as an activator for expression of the IMEI gene product and possibly at other points downstream in the pathway (14) . Once these conditions are met, a cascade of regulatory proteins results in the timed expression of meiosis-specific genes. A number of other genes have been identified, named UMEI to UME5, that allow unscheduled expression of meiosis-specific genes (32) . It In this report, we examine the regulation of HOPJ, a gene expressed early in meiosis. The HOPJ gene was isolated from S. cerevisiae by using a screen designed to detect mutants specifically defective in homologous chromosonme pairing, which occurs during prophase I of meiosis. Therefore, hopl diploids produce spores that are chromosomally imbalanced and inviable (11) . The observation that a fragment containing the HOPJ sequence along with 207 bp upstream of the HOP1 translation start site is able to complement a hopl diploid suggested that all the promoter and regulatory sites required for the proper expression of HOPJ lie within this small upstream region (12) . In this report, we describe the isolation of two sites within the 207-bp promoter region that are required for proper transcriptional regulation and full expression of the HOPJ gene. One of these sites, which we call URS1H, has also been found to regulate genes involved in nitrogen metabolism (34) as well as other meiosis-specific genes (3) . The second site, called UASH, is similar to the site of action of the mammalian C/EBP factor and has not been previously implicated in the control of meiosis-specific genes.
MATERIALS AND METHODS
Yeast strains and media. The genotypes of the strains used in this study are presented in Table 1 . Strain AJ87 is the diploid product of a mating between strains EG123 and 246-1-1 (28) . Strains dipl7-2(2-26), 2273-1-2, and 5762-6-2 are from Hollingsworth and Byers (11) . 7234 is from T. Formosa. The diploid YV16 containing the various hopl-lacZ test constructs was generated by transforming one of the haploid parents (either 5762-6-2 or 2273-1-2) with the appropriate plasmid and then mating to the other haploid parent. This was necessary because the selectable marker was URA3 and the YV16 diploid is heteroallelic at UR43. This particular genetic background was chosen to be consistent with that used in previous work (12 Lowercase letters indicate bases that differ from the HOP1 promoter sequence and were introduced for purposes of cloning. Site-directed mutagenesis of HOPI promoter. Plasmid pNH44-1 contains the 2.7-kb EcoRI-EcoRV fragment of the HOP1 gene cloned into the EcoRI-HincII backbone of pVZ1, a derivative of pBS+ (Stratagene) given to N.H. by Steve Henikoff. The HOP1 EcoRI-EcoRV fragment contains 1 kb of DNA upstream from the start of the protein along with the first 519 codons of the HOP) coding sequence. Specific mutations in the HOP) promoter which create unique restriction sites were constructed in plasmid pNH44-1 by site-directed oligonucleotide mutagenesis with the dut-ung-system and verified by restriction digests (31) . Plasmids pNH71-3 (URS1H), pNH74-7 (SP1H), and pNH76-3 (UASH) (sites in parentheses indicate the mutated site) were constructed by using URSlH (XhoI), SP1H (XhoI), and UASH (EcoRV) mutagenic oligonucleotides, respectively. Plasmids containing double mutations, pNH78-1 (URSlH, UASH), pNH82-18 (SPlH, UASH), and pNH86-2 (URS1H, SP1H), were constructed by site-directed mutagenesis of plasmid pNH71-3 or pNH76-3. The HOP) promoter mutations were used to generate two sets of plasmids described below. One set contains the mutations upstream of a hopl-lacZ gene fusion. These plasmids were used to monitor HOPI expression by assaying 3-galactosidase activity. In the second set of plasmids, the mutant sites were placed upstream of the intact HOP1 gene and used to monitor complementation.
Construction of hopl-lacZ fusion plasmids. The vector pAV71 was used for construction of the hopl-lacZ fusion plasmids. pAV71 is a variant of pLGA312S (a 2,u, URA3 vector containing the cycl-lacZ promoter fusion [9] ) that contains a BgIII site in place of the SmaI site at bp -312 of the CYC1 promoter. hopl-lacZ fusion plasmids were constructed by inserting the 552 bp BglII-XbaI fragment from either pNH44-1 or the mutant variants (pNH71-3, pNH74-7, pNH76-3, pNH78-1, and pNH82-18) into the BglII-BamHI Aliquots were taken every 2 h to assay for hopl-lacZ expression, meiotic recombination, and plasmid stability. Cells were plated on SD-ade plates to assay meiotic recombination by scoring for the presence of Ade+ prototrophs arising from recombination between the ade2-1 and ade2-R8 alleles. Sporulation efficiency was assayed by first diluting the cells 1:1 in 3.7% formaldehyde to fix them and then using a light microscope to detect the formation of asci. Plasmid stability was measured by titering cells on SD-ura and YEPD. 1-Galactosidase assays were performed as described by Keleher et al. (15) without the addition of glucose. A similar protocol was used to obtain the expression data in Fig. 3 to 5 except that the cells were first grown to saturation in selective medium, diluted 10-fold into YEPD, and then grown again to saturation at 30°C before being transferred to SPM for 24 h.
Heterologous promoter constructs and assays. Plasmid pAV73 is a derivative of pLGA312S (9) that contains a cycl-lacZ fusion under the control of the CYCJ promoter, the yeast 2,u origin, the fl origin of replication for production of single-strand DNA, and genes encoding URA3 and 1-lactamase. Plasmid pAV128-1 contains the blunt-ended 103-bp BglII-PstI (-206 to -103) fragment of the HOPJ promoter from pNH44-1 inserted into the blunt-ended XhoI sites in the CYC1 promoter of pAV73. Mutant derivatives of pAV128-1, plasmids pAV128-15 (URS1H), pAV134 (UASH), and pAV135 (URSlH, UASH), were constructed in a similar manner except that the 103-bp HOP1 promoter fragments containing the mutations were cloned from plasmids pNH71-3, pAV130, and pAV131, respectively. Plasmid pAV148 contains the wild-type blunt-ended 103-bp BglIIPstI fragment from pNH44-1 cloned into the SmaI site upstream of the CYCI promoter in plasmid pAV72. pAV157 was constructed in a similar manner except that the HOPI promoter fragment contains the URSlH mutation from plasmid pAV124.
Plasmids pAV138-1, pAV138-2, and pAV138-3 contain one, two, and three copies, respectively, of the URS1H-20 double-stranded oligonucleotide cloned into the XhoI site of pAV73. Plasmids pAV140-1, pAV140-2, and pAV140-5 contain one, two, and five copies, respectively, of the URS1H-8 oligonucleotide cloned into the XhoI site of pAV73. Plasmids pAV141-1, pAV141-2, and pAV141-3 contain one, two, and three copies, respectively, of URS1H-20 cloned into the XAhoI site of pLR1A21, a vector that contains a gall-lacZ fusion under the control of the GALl promoter (38) . Plasmids pAV178-1 and pAV179-1 contain one copy each of the URS1H-20 and UASH-13 sites, respectively, inserted into the Sall site of pASS, a cycl-lacZ vector that is missing the endogenous CYCJ UAS sites. All constructs were screened by restriction digest and verified by sequencing. ,B-Galactosidase assays on the CYCl and GALl heterologous test promoter constructs were performed in strain AJ87. Cells transformed with CYCl constructs were grown on SD-ura to late-log growth, and 0-galactosidase assays were performed as described previously (15) . GALl constructs were grown on SG-ura medium instead of SD-ura. URSlH repression in ssn6 and tupl mutant strains was tested by 0-galactosidase assays of CKY11 and CKY54A (Table 1) transformed with plasmids pAV73, pAV138, pAV148, and pAV157. Assays were performed as described above except that since these strains are clumpy, the cell density was measured in assay buffer with the addition of 5 mM EDTA. URSlH repression in the ume mutant strains was assayed by comparing the levels of 3-galactosidase expression in cells transformed with plasmids pAV73, pAV128-1, and pAV148. Meiotic induction of the hopl-lacZ fusion in the rmel, imel, and ime2 mutant strains was monitored by 3-galactosidase filter assays of pAV79 transformants grown on SD-ura or SPM plates. (12) . Analysis of RNA prepared from diploid cells at various stages after meiotic induction by Northern (RNA) blots indicates that the HOP1 transcripts are induced 3 to 6 h after the cells have been transferred to SPM. To easily assay expression of the HOP1 promoter, we constructed a plasmid, pAV79, which contains a hopl-lacZ gene fusion. A fragment encoding the first 115 residues of the HOP1 protein along with 207 bp of the promoter region was joined in frame to the lacZ gene. We tested whether the hopl-lacZ fusion was induced during meiosis and whether it followed the same temporal pattern of expression as HOP]. The diploid strain, YV16 (Table 1) , was transformed with pAV79, transferred to SPM at 30°C, and assayed at various times for 3-galactosidase activity. In addition, plasmid stability, meiotic recombination, and ascus formation were monitored. YV16 is heteroallelic at ade2, and therefore, meiotic recombination can be detected by the generation of Ade+ prototrophs in return-to-growth experiments (27) . Expression of the fusion protein first appears between 2 and 4 h after switching to SPM (Fig. 1) , a time slightly earlier than was previously reported for the detection of the HOP1 transcript (12) . This difference is probably due to the higher sensitivity of 3-galactosidase detection when compared with Northern analysis. Induction of Ade+ prototrophs occurs between 6 and 8 h as was previously reported for this strain (11) . Therefore, the HOP1 gene is expressed approximately 2 to 4 h before the onset of meiotic recombination. Expression of the hopl-lacZ fusion protein is induced at least 400-fold, and the level of ,-galactosidase activity appears to be maintained from 12 to 24 h after the cells are switched to SPM. The hopl-lacZ fusion protein is not expressed in normal haploid cells under sporulation conditions or in diploid cells during vegetative growth (data not shown). This indicates that the fusion protein has the same genetic and nutritional requirements for meiotic expression as endogenous HOP] (12) . These experiments show that the 207-bp region immediately upstream of the HOP1 translation start site is sufficient for normal regulation of expression of the HOP] gene. The sequence of this region of the HOP1 promoter is shown in Fig. 2 (from reference 12) .
Two regulatory sites in the HOP) promoter are required for proper timing and levels of expression. A series of deletions and site-directed mutations in the HOP1 promoter were constructed to identify the regulatory sites in this region that control expression of HOP]. To test whether any transcriptional regulatory sites reside within the HOP] coding region itself, as has been reported for the meiotically induced gene SPOll (C. Atcheson, cited in reference 3), a hopl-lacZ fusion was constructed containing the 207-bp promoter sequence and only the first six residues of HOP1 fused to lacZ (pAV119). The mitotic and meiotic levels of 3-galactosidase expression of pAV119 are the same as for pAV79, indicating that there are no required regulatory sites between amino acids 6 and 115 of HOP1 (Fig. 3) . Plasmid pAV126 contains a deletion of the promoter from the BglII site (-207) (33) . The URS1 site is also found upstream of genes involved in nitrogen metabolism and other meiosis-specific genes (3, 34) . In one case, it was shown to be required for meiotic expression (3).
To determine whether URSlH is involved in the regulation and/or expression of the HOP] promoter, we altered the site by directed mutagenesis. The resulting mutant promoter was then cloned either upstream of the hopl-lacZ fusion to assay for expression or upstream of the intact HOP1 gene to test its ability to complement a hopl diploid. A 5-bp mutation in the URS1H site (Fig. 2) affects expression of hopl-lacZ in both mitotic and meiotic cells (pAV124, Fig. 3) . In mitotic cells, the mutation causes a 140-fold increase in expression of the fusion protein; that is, the gene is derepressed. In cells undergoing meiosis, this mutant fails to show any induction of expression above the mitotic level; this level is eightfold lower than that shown by the wild-type promoter during meiosis. In complementation tests, the mutant fails to complement a diploid hopl strain (pNH73-26, Fig. 3 region (pAV132, Fig. 3 ). However, a deletion of the region between -207 and the mutant URSlH site at -170 abolishes expression in mitotic cells (pAV125, Fig. 3 ). Inspection of this region revealed a sequence, GTGTGAAGTG (-199 to -190) , that resembles (six of nine match) the recognition sequence of the mammalian transcriptional regulatory factor CCAAT enhancer binding protein (C/EBP) (13) . A site-directed mutation which changes 8 bp (Fig. 2) at this site in a URSlH mutant background failed to express the fusion protein in mitotic or meiotic cells (pAV131, Fig. 3 ). This result suggests that this second regulatory site, which we call UASH, functions as an activator sequence in mitotic cells.
We next tested whether the UASH mutation has any effect on an otherwise wild-type promoter. As expected, the UASH mutation in a wild-type promoter background does not express the fusion protein in mitotic cells. Upon being shifted to sporulation conditions, the mutant promoter is induced to a level fourfold below that of wild type (pAV130, Fig. 3 ). When the UASH-mutated promoter is placed upstream of the intact HOPI gene, this construct can no longer complement a hopl diploid (pNH80-7, Fig. 3 ). We presume, therefore, that the fourfold decrease in expression resulting from the UASH mutation prevents sufficient HOP1 protein from being made. Note that the level of HOP1 expression observed in UASH mutants during sporulation is similar to the unregulated level of transcription in URSlH mutants during both mitosis and sporulation. The fact that both mutants fail to complement rules out the possibility that failure of the URSlH mutant was due to premature expression. These results indicate that the UASH site acts as an activator sequence and is required for full meiotic induction of the HOPI promoter.
There exists another G+C-rich region within the HOP1 promoter, which we call SPlH (-127 to -120), that is similar to the variant Spl site (GGGAGG) found in the human cardiac a-actin promoter (10) . A HOP1 promoter that contains a 4-bp mutation of the SP1H site (Fig. 2) exhibited no phenotype in mitotic or meiotic cells (pAV127, Fig. 3 ). This mutation also fully complemented hopl diploid cells (pNH75-3, Fig. 3 ). Therefore, we conclude that the SP1H site is not important for expression of HOPJ.
URS1H site is able to repress heterologous promoters. The derepression of HOPI expression caused by the URSlH mutant suggests that this sequence functions as a repressor site in mitotic cells. We wanted to test whether this site would repress transcription when placed in a nonmeiotic promoter. Plasmid pAV128-1 contains a 103-bp fragment (-206 to -103) from the wild-type HOPJ promoter cloned between the UAS and the TATA of the CYCI promoter. This fragment contains the HOPI URS1H and UASH sites (Fig. 2) . The CYCl promoter in this construct directs transcription of a cycl-lacZ fusion protein (9) . Transformants containing this plasmid were assayed for cycl-lacZ expression by monitoring ,-galactosidase activity under mitotic and meiotic conditions. When compared with a plasmid without an insert, the wild-type HOPJ fragment repressed transcription approximately 1,400-fold (pAV73 versus pAV128-1, Fig. 4) . A similar construct with the URSlH mutation repressed transcription 36-fold (pAV128-1 versus pAV128-15, Fig. 4 ). Therefore, a large part of the observed repression (40-fold) appears to be dependent solely on the URSlH site. The 1,400-fold repression of the CYCI promoter by the wild-type HOP1 fragment cannot be attributed to an alteration of the spacing between the CYCl UAS and TATA, since this fragment repressed transcription 30-fold when placed upstream of the CYCI UAS (pAV148, Fig. 4) . Furthermore, this upstream repression was completely eliminated by the presence of the URSlH mutation (pAV157, Fig. 4 Constructs were assayed for 0-galactosidase expression in the strain AJ87 as described in Materials and Methods (see Table 1 
URS1H-20
C PLASMID URS1H appears to function as both an activator and a repressor site, while UASH only serves as an activator site. Therefore, we predicted that UASH mutants should have no effect on the ability of URS1H to repress transcription in the heterologous system. This was indeed the case. The plasmid pAV134, carrying the UASH mutation in the HOPJ promoter fragment, repressed transcription 850-fold (Fig. 4) .
To roughly define the boundaries of the URSlH site in the HOPJ promoter, we synthesized oligonucleotides centered around the URSlH site and cloned them between the UAS and TATA sites of the CYCl test promoter. A construct that contains one copy of the 20-bp URS1H site, called URS1H-20 (see Material and Methods for the sequence), repressed CYCl transcription 77-fold (pAV138-1, Fig. 5a ). Constructs that contain two or three copies of the URSH-20 oligonucleotide repressed transcription 4,000-fold, suggesting that multiple repressor sites function cooperatively. In contrast, plasmids constructed with one or five copies of an oligonucleotide containing only eight bases centered around the URS1H site, URS1H-8, failed to show any repression of the CYCl promoter (pAV140-1 and pAV140-5, Fig. 5a ). This indicates that in addition to the URS1H-8 site, sequences within the 20-bp site are required for repression (Fig. 2) .
The ability of URSlH to repress a heterologous promoter is not limited to the CYCl gene; similar experiments were done placing URSlH within the GALl promoter with the same results (Fig. 5b) . The observation that the URSlH site can effect repression of several different yeast promoters raises the question of whether URS1H-mediated repression requires some of the same proteins as are used in other yeast repression systems. For example, it has been shown that the SSN6 and TUP1 proteins are required for repression of genes involved in determining cell mating type as well as the response to glucose availability (4, 16, 24, 36) . URS1H-mediated repression of the cycl-lacZ promoter was tested in ssn6 and tupl mutant strains and was found to be unaffected The hatched boxes indicate the number of URSlH-20 sites inserted into plasmid pLRA21. Experiments were performed as described in the legend to Fig. 4 except that cells were grown on galactose instead of glucose. (c) HOPI UASH site functions as an activator sequence. URSlH-20 and UASH-13 sites were inserted into a CYCI-lacZ vector missing the CYCl UAS sites, and constructs were assayed as described in the legend to Fig. 4. (data not shown). This result indicates that URSlH-mediated repression utilizes a set of proteins at least some of which are distinct from those required by other repression systems.
What proteins are responsible for the mitotic repression of HOPJ? The UMEl-S genes were identified from mutants that allow expression of meiotic genes during vegetative growth (32) . It therefore seemed reasonable that some of these proteins might be required to mediate repression at the HOPJ URS1H site. However, we found less than a twofold difference in the level of URS1H repression in umel, ume2, ume3, ume4, and umeS strains when compared with wild type (data not shown).
HOP1 UASH site functions as an independent activator (Fig. 5c) . The URSlH site failed to show any activation of transcription above background levels during mitotic or meiotic growth. This result suggests that there are other sequences within the HOPI promoter that are required for activation by the URSlH site. The UASH site in pAV179-1 activates transcription of the promoter about 10-fold above background levels (compare pAV179-1 to pASS in Fig. 5c ) in both mitotic and meiotic cells, indicating that it can function as an independent activator site.
Genetic control ofHOPI expression. The genetic cascade of proteins involved in regulating meiosis has been extensively studied, and it seemed likely that some of these proteins directly or indirectly regulate expression of HOP]. The genetic requirement for initiation of meiosis in yeast cells is the presence of theMA4Ta2 and A4Tal genes. The al and a2 proteins work together to repress transcription of RME1, which encodes a repressor protein that in turn allows the expression of IME] (14, 23) . The IME1 protein functions as an activator protein to express IME2, another activator protein, as well as possibly other meiosis-specific proteins (29, 30) . Previous work demonstrated that HOP] is under the control of the AVT locus (12) . This finding was confirmed by the observation that the hopl-lacZ fusion was expressed in a haploid strain (AMP118) under sporulation conditions if the strain is mutant in RMEl ( (3) . We noticed that many of these genes contain sequences with some similarity, although weak, to the HOP] UASH site (Fig. 6) . It is noteworthy that DMC], a meiosis-specific gene which is required for formation of the synaptonemal complex, contains an 11 of 13 match to the UASH site in its promoter (2) . With the exception of the SP013 URS1 site, which has been shown to be required for meiotic induction (3), it is not currently known which of these sites are important for meiotic regulation or expression. However, it seems likely that many of itotic growth, and it seems likely that the signal for meiotic directly regulated by nitrogen starvation, then it seems likely luction works at least partially through this site. The that the URS1 site is the site of action of these common AS. site. on the other hand, appears simply to increase the factors. induced level of transcription of the HOPI promoter. It is possible that meiotic genes that are not as highly expressed as is HOP1 may not require a second activator site like UASH. In these cases, activation from the URS1 site alone would be sufficient.
The URS1H site was first identified by sequence inspection: it is homologous to the binding site for the mammalian transcription factor, Spl (12) . The full repression site is contained within the 20-bp synthetic oligonucleotide URS1H-20. This site bears a striking similarity (eight of nine match) to the upstream repression sequence URS1 of CAR1, a gene involved in arginine metabolism (19, 33) . Furthermore, Luche et al. (19) have shown that the URS1 site consists of 9 bp, consistent with our finding that the 20-bp URS1H-20 oligonucleotide brings about repression, but the 8-bp oligonucleotide does not. The URS1 site functions in vivo as both a repressor and activator site for CAR1 expression and has been shown to function as a repressor site in heterologous test promoters (18) . Sites homologous to URS1 have subsequently been located upstream of a large number of genes involved in cellular metabolism (34) . The results from this study suggest a model of HOP1 regulation that resembles the mechanism of regulation of CARl expression and may even involve some of the same transcriptional regulatory factors (18) .
In the context of the HOPI promoter, we showed that
